Viewing Study NCT04911166


Ignite Creation Date: 2025-12-24 @ 4:36 PM
Ignite Modification Date: 2025-12-27 @ 9:51 PM
Study NCT ID: NCT04911166
Status: TERMINATED
Last Update Posted: 2025-06-17
First Post: 2021-05-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Trial of Atezolizumab and Interleukin-12 Gene Therapy in Metastatic Non-Small Cell Lung Cancer With Progression on First-Line Immunotherapy With or Without Chemotherapy
Sponsor: The Methodist Hospital Research Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module